Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May 15;12(5):e0177763.
doi: 10.1371/journal.pone.0177763. eCollection 2017.

Extracellular matrix nitration alters growth factor release and activates bioactive complement in human retinal pigment epithelial cells

Affiliations

Extracellular matrix nitration alters growth factor release and activates bioactive complement in human retinal pigment epithelial cells

Mark A Fields et al. PLoS One. .

Abstract

Purpose: We have shown previously that non-enzymatic nitration (NEN) of the extracellular matrix (ECM), which serves as a model of Bruch's membrane (BM) aging, has a profound effect on the behavior of the overlying retinal pigment epithelial (RPE) cells, including altered phagocytic ability, reduced cell adhesion, and inhibition of proliferation. We know that transplanted RPE monolayers will encounter a hostile sub-RPE environment, including age-related alterations in BM that may compromise cell function and survival. Here we use our previous NEN model of BM aging to determine the effects of NEN of the ECM on growth factor release and complement activation in RPE cells.

Methods: Human induced-pluripotent stem cells (iPSCs) were differentiated into RPE cells, and confirmed by immunohistochemistry, confocal microscopy, and polymerase chain reaction. IPSC-derived RPE cells were plated onto RPE-derived ECM under untreated or nitrite-modified conditions. Cells were cultured for 7 days and barrier function measured by transepithelial resistance (TER). Vascular endothelial growth factor (VEGF), pigment epithelium-derived factor (PEDF), and complement component C3a were measured using enzyme-linked immunosorbent assay (ELISA).

Results: On average nitrite-modified ECM increased VEGF release both apically and basally by 0.15 ± 0.014 ng/mL (p <0.0001) and 0.21 ± 0.022 ng/mL (p <0.0001), respectively, in iPSC-derived RPE cells. Nitrite-modified ECM increased PEDF release in iPSC-derived RPE cells apically by 0.16 ± 0.031 ng/mL (p <0.0001), but not basally (0.27 ± 0.015 vs. 0.32 ± 0.029 ng/mL, (p >0.05)). Nitrite-modified ECM increased production of C3a in iPSC-derived RPE cells by 0.52 ± 0.123 ng/mL (p <0.05).

Conclusion: Nitrite-modified ECM increased VEGF, PEDF release, and C3a production in human iPSC-derived RPE cells. This model demonstrates changes seen in the basement membrane can lead to alterations in the cell biology of the RPE cells that may be related to the development of age-related macular degeneration.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Differentiation of human induced-pluripotent stem cells (iPSCs) into iPSC-derived retinal pigment epithelial (RPE) cells from 2 different donors.
Immunofluorescent staining was positive for Oct-4, Nanog, Sox-2, and TRA-1-60 (A). Nuclei stained with DAPI (blue). Undifferentiated human iPSC colony (B) and eventual formation into embryoid bodies (C). Formation of neural rosettes by day 14 post-differentiation (D), and a pigmented monolayer of iPSC-derived RPE cells forms by day 45 post-differentiation (E). Scale bar for A and E = 50 μm.
Fig 2
Fig 2. Expression and localization of retinal pigment epithelial (RPE) cell markers in human iPSC-derived RPE.
Immunofluorescent staining was positive for bestrophin, Na + /K + ATPase, RPE65, and ZO-1 (A). Nuclei stained with DAPI (blue). Scale bar for A = 50 μm.
Fig 3
Fig 3. Transepithelial resistance (TER) of iPSC-derived RPE cells on RPE cell-derived ECM and nitrite-modified RPE cell-derived ECM.
Monolayer permeability was assessed by TER in polarized iPSC-RPE cells. TER measurements were 209.5 and 209.3 Ω*cm2 for iPSC-derived RPE cells cultured on untreated extracellular matrix. iPSC-derived RPE cells cultured on nitrite-modified ECM were (225.8 and 207.3 Ω*cm2) from donor one and two samples, respectively.
Fig 4
Fig 4. VEGF release in iPSC-derived RPE cell monolayers on RPE cell-derived ECM and nitrite-modified RPE cell-derived ECM.
iPSC-derived RPE cells release of vascular endothelial growth factor (VEGF) on nitrite-modified ECM (nitrite) and untreated ECM (PBS) both apically and basally. ****p <0.0001.
Fig 5
Fig 5. PEDF release in iPSC-derived RPE cell monolayers on RPE cell-derived ECM and nitrite-modified RPE cell-derived ECM.
iPSC-derived RPE cell release of pigment epithelium-derived factor (PEDF) increased on nitrite-modified ECM (nitrite) apically. **** p <0.001.
Fig 6
Fig 6. C3a production in iPSC-derived RPE cell monolayers on RPE cell-derived ECM and nitrite-modified RPE cell-derived ECM.
iPSC-derived RPE cell C3a production increased on nitrite-modified ECM (nitrite). * p <0.0001.
Fig 7
Fig 7. Effects of nitrite modification on VEGF, PEDF and C3a in iPSC-derived RPE cells.
Release of VEGF, PEDF and c3a from patient-derived iPSC-RPE cells on normal versus “aged” extracellular matrix is represented diagrammatically. VEGF release is higher basally than apically on normal basement membrane (A). Cross-linking of collagen in the basement membrane increased release of VEGF both apically and basally in iPSC-derived RPE cells while preserving this polarity (A). PEDF release is higher apically than basally on normal basement membrane (B). Cross-linking of collagen in the basement membrane increased release of PEDF apically, and preserved this polarity (B). Cross-linking of collagen in the basement membrane increased release of C3a in iPSC-derived RPE cells (C). The aging of Bruch’s membrane increases VEGF (apical and basal) and PEDF (apical and basal) release in the RPE cells as well as C3a production. Increased release of these factors may contribute to the pathology at the site of RPE cells seen in exudative and advanced dry age-related macular degeneration (AMD) or geographic atrophy.

Similar articles

Cited by

References

    1. Wiradjaja F, DiTommaso T, Smyth I. Basement membranes in development and disease. Birth Defects Res C Embryo Today. 2010;90(1):8–31. doi: 10.1002/bdrc.20172 - DOI - PubMed
    1. Nystrom A, Bornert O, Kuhl T. Cell therapy for basement membrane-linked diseases. Matrix Biol. 2016. - PubMed
    1. Pauleikhoff D, Harper CA, Marshall J, Bird AC. Aging changes in Bruch's membrane. A histochemical and morphologic study. Ophthalmology. 1990;97(2):171–8. Epub 1990/02/01. - PubMed
    1. Marshall GE, Konstas AG, Reid GG, Edwards JG, Lee WR. Type IV collagen and laminin in Bruch's membrane and basal linear deposit in the human macula. Br J Ophthalmol. 1992;76(10):607–14. Epub 1992/10/01. PubMed Central PMCID: PMC505233. - PMC - PubMed
    1. Pauleikhoff D, Harper CA, Marshall J, Bird AC. Aging changes in Bruch's membrane. A histochemical and morphologic study. Ophthalmology. 1990;97(2):171–8. - PubMed

MeSH terms